Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
Combined glucose-lowering therapy, comprising of basal insulin with glucagon-like peptide-1 (GLP-1) analogues, has become central to the treatment of type 2 diabetes both at the start of insulin therapy, and as an alternative to basal-bolus insulin. The combination of insulin detemir (insulin analog...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN RU |
| Published: |
Endocrinology Research Centre
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/3e6b1c403d2245b08a42415262fb3420 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|